DD121636A5 - - Google Patents

Info

Publication number
DD121636A5
DD121636A5 DD188214A DD18821475A DD121636A5 DD 121636 A5 DD121636 A5 DD 121636A5 DD 188214 A DD188214 A DD 188214A DD 18821475 A DD18821475 A DD 18821475A DD 121636 A5 DD121636 A5 DD 121636A5
Authority
DD
German Democratic Republic
Application number
DD188214A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD121636A5 publication Critical patent/DD121636A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD188214A 1974-09-06 1975-09-05 DD121636A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50358174A 1974-09-06 1974-09-06

Publications (1)

Publication Number Publication Date
DD121636A5 true DD121636A5 (fr) 1976-08-12

Family

ID=24002675

Family Applications (1)

Application Number Title Priority Date Filing Date
DD188214A DD121636A5 (fr) 1974-09-06 1975-09-05

Country Status (27)

Country Link
US (1) US4081450A (fr)
JP (3) JPS5929588B2 (fr)
AR (1) AR206937A1 (fr)
AT (1) AT350567B (fr)
BE (1) BE833044A (fr)
BG (2) BG24802A3 (fr)
CA (1) CA1069901A (fr)
CH (1) CH625787A5 (fr)
CS (1) CS188237B2 (fr)
DD (1) DD121636A5 (fr)
DE (1) DE2539452A1 (fr)
DK (1) DK153397C (fr)
ES (1) ES440771A1 (fr)
FR (2) FR2283679A1 (fr)
GB (1) GB1525584A (fr)
HU (1) HU173057B (fr)
IE (1) IE41610B1 (fr)
IL (1) IL48003A (fr)
NL (1) NL7510535A (fr)
NZ (1) NZ178501A (fr)
PH (2) PH12618A (fr)
PL (3) PL100438B1 (fr)
RO (1) RO68142A (fr)
SE (1) SE425489B (fr)
SU (2) SU629875A3 (fr)
YU (2) YU221675A (fr)
ZA (1) ZA755614B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284635A (en) * 1978-11-29 1981-08-18 Eli Lilly And Company Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines
FR2451368A1 (fr) * 1979-03-12 1980-10-10 Lilly Co Eli Phenylmorphanes, intermediaires et procedes de synthese, et leur utilisation therapeutique
ZA813127B (en) * 1980-05-13 1982-05-26 May & Baker Ltd A new phenylpropargylamine derivative
CH646696A5 (de) 1980-11-28 1984-12-14 Sandoz Ag Dibenzazepine, ihre herstellung und verwendung.
FR2518093A2 (fr) * 1980-12-15 1983-06-17 Roussel Uclaf Nouveaux derives de l'hydroxyphenyl tetrahydropyridine, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant
US4931558A (en) * 1983-09-21 1990-06-05 Eli Lilly And Company Processes for preparing intermediates of picenadol
US4581456A (en) * 1983-09-21 1986-04-08 Eli Lilly And Company Processes for preparing picenadol precursors and novel intermediates thereof
US4678638A (en) * 1985-07-24 1987-07-07 Petrolite Corporation Highly branched amino hexahydropyridines
ES2058265T3 (es) * 1987-04-16 1994-11-01 Lilly Co Eli Piperidinas antagonistas de opiaceos.
US5319087A (en) * 1987-04-16 1994-06-07 Eli Lilly And Company Piperidine opioid antagonists
EP0299549A3 (fr) * 1987-07-09 1989-02-08 Duphar International Research B.V 3,5-Dialkyl-3-phényl-pipéridines avec une activité antagoniste des opiates
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
US5270328A (en) * 1991-03-29 1993-12-14 Eli Lilly And Company Peripherally selective piperidine opioid antagonists
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
GB9725114D0 (en) * 1997-11-28 1998-01-28 Pfizer Ltd Treatment of pruritus
GB9810671D0 (en) * 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
GB9912415D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912417D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912416D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912411D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US7045527B2 (en) * 2002-09-24 2006-05-16 Amgen Inc. Piperidine derivatives
US10519111B2 (en) 2013-07-15 2019-12-31 Coral Sunscreen Pty Ltd UV absorbing compounds, compositions comprising same and uses thereof
BR112016000844A8 (pt) * 2013-07-15 2020-01-07 Coral Sunscreen Pty Ltd compostos absorvedores de uv, composições que compreendem os mesmos, usos destes e método de proteger uma superfície ou tecido dos raios uv

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD87036A (fr) *
US2892842A (en) * 1959-06-30 Their preparation
US1915334A (en) * 1930-10-16 1933-06-27 Du Pont Fluosilicate of organic heterocyclic bases and process of making it
US2075359A (en) * 1930-10-16 1937-03-30 Du Pont Insecticide
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
US3936468A (en) * 1969-10-27 1976-02-03 Sumitomo Chemical Company, Ltd. Phenylbutanol derivatives

Also Published As

Publication number Publication date
YU221675A (en) 1982-02-28
YU233681A (en) 1982-02-28
ES440771A1 (es) 1977-04-01
IL48003A0 (en) 1975-11-25
GB1525584A (en) 1978-09-20
IE41610L (en) 1976-03-06
HU173057B (hu) 1979-02-28
JPS6026782B2 (ja) 1985-06-25
SE425489B (sv) 1982-10-04
DK153397C (da) 1988-12-05
FR2299337B1 (fr) 1979-01-19
FR2299337A1 (fr) 1976-08-27
BG24802A3 (en) 1978-05-12
AT350567B (de) 1979-06-11
CH625787A5 (fr) 1981-10-15
BE833044A (fr) 1976-03-03
PL100438B1 (pl) 1978-10-31
PH12618A (en) 1979-07-05
SU621316A3 (ru) 1978-08-25
AR206937A1 (es) 1976-08-31
US4081450A (en) 1978-03-28
JPS5148670A (fr) 1976-04-26
NL7510535A (nl) 1976-03-09
NZ178501A (en) 1978-09-20
BG24950A3 (en) 1978-06-15
JPS5916875A (ja) 1984-01-28
JPS5929588B2 (ja) 1984-07-21
PH14016A (en) 1980-12-08
JPS6051174A (ja) 1985-03-22
DK397575A (da) 1976-03-07
PL108465B1 (en) 1980-04-30
ATA685275A (de) 1978-11-15
RO68142A (fr) 1981-08-30
SU629875A3 (ru) 1978-10-25
DK153397B (da) 1988-07-11
ZA755614B (en) 1977-04-27
IL48003A (en) 1981-01-30
CA1069901A (fr) 1980-01-15
FR2283679A1 (fr) 1976-04-02
DE2539452A1 (de) 1976-03-18
IE41610B1 (en) 1980-02-13
JPS6012350B2 (ja) 1985-04-01
CS188237B2 (en) 1979-02-28
AU8431375A (en) 1977-03-03
FR2283679B1 (fr) 1979-09-14
PL117501B1 (en) 1981-08-31
SE7509640L (sv) 1976-03-08

Similar Documents

Publication Publication Date Title
FR2299337B1 (fr)
AU495930B2 (fr)
CH566410A5 (fr)
BG21634A1 (fr)
AU480208A (fr)
AU480247A (fr)
AU480471A (fr)
AU480758A (fr)
AU480863A (fr)
BG19768A1 (fr)
BG19847A1 (fr)
BG19987A1 (fr)
BG20440A1 (fr)
BG20446A1 (fr)
BG20451A1 (fr)
BG20462A1 (fr)
BG20638A1 (fr)
BG20854A1 (fr)
BG20883A1 (fr)
BG20885A1 (fr)
CH563933A5 (fr)
BG21129A1 (fr)
BG21307A1 (fr)
BG21351A1 (fr)
BG21352A1 (fr)